The baseline and postintervention mean hemoglobin levels were 9.27 and 10.47 g/dL in the Treatment A , and 9.63 g/dL and 9.54 g/dL in the Treatment B group , respectively ( treatment effect P = 0.039 , period effect P = 0.001 , carryover effect P = 0.060 ) .